GOLDMAN SACHS GROUP INC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,737
+63.8%
22,606
-9.0%
0.00%
Q2 2023$4,112
-91.4%
24,847
-49.4%
0.00%
Q1 2023$47,906
-7.4%
49,084
-1.3%
0.00%
Q4 2022$51,743
-30.1%
49,753
-23.1%
0.00%
Q3 2022$74,000
-50.3%
64,683
-18.7%
0.00%
Q2 2022$149,000
-74.8%
79,532
-59.2%
0.00%
Q1 2022$591,000
-67.6%
195,010
-59.6%
0.00%
Q4 2021$1,824,000
-29.2%
482,655
-3.2%
0.00%
-100.0%
Q3 2021$2,578,000
+3043.9%
498,581
+2240.3%
0.00%
Q2 2021$82,000
-86.5%
21,304
-91.0%
0.00%
Q1 2021$609,000
-21.7%
237,187
-23.8%
0.00%
Q4 2020$778,000
+11.6%
311,224
-7.7%
0.00%
Q3 2020$697,000
-36.8%
337,112
-5.2%
0.00%
Q2 2020$1,103,000
+45.3%
355,706
+6.8%
0.00%
Q1 2020$759,000
-30.6%
333,181
+10.2%
0.00%
Q4 2019$1,094,000
-4.5%
302,355
-10.0%
0.00%
Q3 2019$1,146,000
-48.6%
336,121
-29.1%
0.00%
-100.0%
Q2 2019$2,228,000
+22.6%
474,035
-12.6%
0.00%0.0%
Q1 2019$1,817,000
+9.3%
542,397
-13.2%
0.00%0.0%
Q4 2018$1,662,000
-53.7%
624,869
-2.5%
0.00%0.0%
Q3 2018$3,590,000
+1.3%
641,094
-8.3%
0.00%0.0%
Q2 2018$3,544,000
-22.1%
699,041
+4.8%
0.00%0.0%
Q1 2018$4,550,000
+129.9%
667,065
+154.4%
0.00%
Q4 2017$1,979,000
+244.2%
262,220
+162.6%
0.00%
Q3 2017$575,000
+858.3%
99,844
+735.4%
0.00%
Q2 2017$60,00011,9520.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 5,628,585$5,853,7285.06%
Aquilo Capital Management, LLC 4,552,876$4,734,9911.78%
BVF INC/IL 5,080,320$5,283,5330.22%
Soleus Capital Management, L.P. 1,000,000$1,040,0000.15%
Cutter & CO Brokerage, Inc. 378,479$393,6180.13%
PLATINUM INVESTMENT MANAGEMENT LTD 1,220,798$1,269,6300.05%
GSA CAPITAL PARTNERS LLP 365,047$3800.05%
Annandale Capital, LLC 67,000$700.02%
WEALTH EFFECTS LLC 21,700$22,5680.01%
Sigma Planning Corp 343,934$357,6910.01%
View complete list of PIERIS PHARMACEUTICALS INC shareholders